Prof. Tim Walsh has been studying AMR mechanisms for over 20 years, has published over 310 papers and publishes regularly in Nature and Lancet journals. He is director of BARNARDS, the lead Gates Foundation project on AMR, examining the burden of neonatal sepsis in Pakistan, India, Bangladesh, Rwanda, South Africa, Nigeria (Abuja and Kano) and Ethiopia. This project enrolled 36,000 mothers and over 38,000 infant cases.
Walsh is also PI of DETER-XDR-CHINA, a study examining the spread and burden of AMR in public health sectors and hospitals in 30 provinces in China. He holds an honorary chair at the Chinese Agricultural University and is an AMR advisor to the Chinese Government and was pivotal in the decision for the Chinese government to ban the use of colistin on farms. He is also PI of CUT-SEC, a ‘one-health” project in China and Thailand.
He has also recently been awarded an MRC grant to establish an AMR surveillance system throughout Vietnam in collaboration with Oxford University and the Wellcome Trust Center in Hanoi. In addition to BARNARDS, he also has AMR studies in Karachi and Peshawar and has collaborative studies with MSF in Jijawa (Nigeria), Niger (Clean Kids Study) and has facilitated the design and construction of the MSF Microbiology/AMR lab in Jordan/Syria. His lab provides molecular support for the Russian Federation Reference Laboratory in AMR surveillance that covers Russia, Belarus and Kazakhstan. He also has clinical studies examining the burden of AMR in the community and hospitals San Paolo (Brazil), Phitsanulok (Thailand) and Tanta (Egypt).
Walsh has also been appointed as a lead microbiologist to the Fleming Fund expert advisory panel – a £265M AMR capacity building program and is country lead for scoping and implementation in Nigeria, Pakistan and Bangladesh. He is also advisor to the UN AMR committee, Chinese CDC and MSF.
In 2020, he was awarded an O.B.E for “Microbiology and International Development”.